COVID INFORMATION

Pfizer Covid-19 Vaccines Have Arrived!

Vaccine Clinic for Residents and Staff


Date To Be Determined - More info to come!


Informed Consent Required!

(See **Pfizer Fact Sheet Below)


Daily  Covid Updates Available at (718) 989-3043
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

RESIDENT  VISITATION

 

UPDATE


(Updated 04/07/2021)
VISITATION HAS BEEN
TEMPORARILY SUSPENDED!


Eger has exceeded the COVID positivity rate
standard established by the DOH resulting in a
suspension of visitation until Monday, April 19th

Please know that Staten Island has a positivity rate of 8.8% which is the highest of all the NYC Boroughs.  

Remain safe by properly wearing a MASK, practice SOCIAL DISTANCING, WASH YOUR HANDS frequently and GET VACCINATED.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

RESIDENT VISITATION GUIDELINES 

(upon resumption of visitation - schedule subject to change)
For Eger Harbor House Visitation Guidelines, please visit the Medicaid Assisted Living Page (tab  above)
(Visitor Testing Information follows Resident Visitation Guidelines below)

 

a/o March 22, 2021

In recognition and support of the vital importance in-person visits have on resident and family well-being, the following guidelines
have been prepared in accordance with the

New York State Department of Health
July 10th Advisory and subsequently, updated on
September 15th, September 17th, November 10th and February 23nd.

 

  • Visitation is contingent upon Eger being COVID-19 Free, residents and employees, for 14 days, and if the county positivity rate is less than 10%. (revised 1/13/21 and 3/8/21)  

 

  • Residents with COVID-19 signs or symptoms and residents in a 14-day quarantine or observation period are ineligible for in-person visits.

 

  • Residents who leave the facility for an outside visit or medical appointment shall be quarantined upon their return for 14-days, are monitored for signs and symptoms of respiratory infection and are ineligible for in-person visits.

 

  • Two (2) visitors maximum per resident per 40-minute session.
     

  • Visitation shall be monitored to ensure compliance with core principles of infection prevention and control in order to reduce the risk of COVID-19 transmission.
     

  • Upon entering the main lobby, each visitor must provide for Eger’s records a verified negative test result within the last 72 hours (effective 2/23/21), have their temperature taken and complete a health screening.  A surgical face mask, to be worn at all times, shall be provided should the visitor not have one.  Cloth masks are not permitted.  Facility provided alcohol based hand sanitizer shall be used in the main lobby and at the visitation site if necessary to maintain proper hand hygiene. (revised 9/17/20, 9/18/20 and 3/8/21)
     

  • Visiting will be accommodated Monday through Friday only, pre-scheduled for a 40-minute duration (updated 10/13/20),
     

  • Visitation is preferred in outdoor areas, weather permitting, as defined by the facility.  Visitation will begin indoors; once the weather gets warmer, visitation will solely be outdoors, until further guidance from DOH is received.
     

  1. Outdoor Visitation
    With social distancing requirements of six (6) feet, the rear yard patio can accommodate no more than twelve (12)  long term care residents  per visitation period and the piano lounge patio will accommodate up to
    seven (7) short term care residents.

     

  2. Indoor Visitation
    Long-term care resident visitation shall be held in the Chapel/Assembly room which can accommodate no more than eight (8) residents per visitation period.


    Short-term care resident visitation shall be in the two (2) large spaces in the Physical Therapy gym adjacent to the main lobby where no more than three (3) residents can be accommodated on each side per visitation period.


SCHEDULE TIMES & INSTRUCTIONS

Scheduling for 40-minute visits will be coordinated by
nursing unit at the following times and day(s):


Long Term Care Residents

(Outdoor and Indoor Times)

10:30am - 11:10am, 11:30am - 12:10pm,
2:00pm-2:40pm , 3:00pm - 3:40pm  
and    4:00pm – 4:40pm

Mon = Unit 8    Tues = Unit 7    Wed = Unit 6   
Thurs = Unit 4    Fri =  Unit 5

Schedule by using this web-link https://www.signupgenius.com/go/10C0C4EABAE2AA2FAC34-visitation

or by calling  718-989-3074

 

        Short Term Care Residents 
(Indoor Times as below*, Outdoor Times as above)

*4:45pm - 5:25pm and *7:00pm - 7:40pm

Mon. through Fri. = Units 2 & 3
Call to Schedule:  718-989-3089
(CALLS ONLY! Web-link is not available for Short Term Scheduling)

 

​​

  • An Eger employee(s) shall transport residents from the nursing unit to the visitation area and back to the nursing unit,

 

  • Visiting will be supervised by an Eger employee to ensure face masks remain in proper position and social distancing requirements are maintained,
     

  • Food shall not be brought to the visitation area; a drink is permitted if the consistency is not contrary to physician ordered restrictions.  Any food brought to the facility shall be left with security to be sent to the nursing unit.

 

  • Visitors under the age of 16 must be accompanied by a person who is at least 18 years old. (revised 9/17/20, 9/18/20 and 3/8/21)

 

  • Eger reserves the right to cancel visiting due to situations outside of our control.
     

Any visitor who fails to adhere to the visiting protocols

shall be prohibited from visiting

for the duration of the COVID-19

state declared public health emergency!

---------------------------------------------------------------------------------------------------------------

Visitor Testing

Commencing Monday, March 22, 2021
Visitor testing via an Abbott BinaxNow point of care antigen test
shall be provided on Mondays and Wednesdays
from 8:45am to 10:00am and 12:30pm to 1:30pm.
(unless otherwise noted above)

 

Prior to the test, required information will be collected for reporting the test results to the State and Federal Government.
 

The COVID testing process will be performed by two Eger employees while the person(s) being tested remain in the car.  Vehicles shall line up along the curb beginning just prior to the blue canopy at the main entrance.
 

Once the swabbing of each nostril is complete, the vehicle shall drive away allowing for testing of the occupants in the next car.  Test results are available 15 minutes after the test.  An Eger employee shall “only” call those who have a “positive” test result.
 

Visitation will be suspended for at least 14 days for anyone receiving a positive test result.  After 14 days, a negative test result is required to visit the facility. Presenting a negative test result performed prior to 14 days after the positive result will not negate the 14 day no visitation requirement.
 

Test results will remain with Eger security for access upon the visit.  Eger reserves the right not to provide a test result to a person who does not visit.
 

Eger strongly recommends anyone receiving a COVID positive test result to contact their primary physician.

(Daily Updates Available at (718) 989-3043)

​- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

**THE PFIZER-BIONTECH COVID-19 VACCINE
FACT SHEET FOR RECIPIENTS AND CAREGIVERS

EMERGENCY USE AUTHORIZATION (EUA) OF

THE PFIZER-BIONTECH COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19)

IN INDIVIDUALS 16 YEARS OF AGE AND OLDER
(Revised: December 2020)

 

You are being offered the Pfizer-BioNTech COVID-19 Vaccine to prevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2. This Fact Sheet contains information to help you understand the risks and benefits of the Pfizer-BioNTech COVID-19 Vaccine, which you may receive because there is currently a pandemic of COVID-19.

 

The Pfizer-BioNTech COVID-19 Vaccine is a vaccine and may prevent you from getting COVID-19. There is no U.S. Food and Drug Administration (FDA) approved vaccine to prevent COVID-19.

 

Read this Fact Sheet for information about the Pfizer-BioNTech COVID-19 Vaccine. Talk to the vaccination provider if you have questions. It is your choice to receive the Pfizer-BioNTech COVID-19 Vaccine.

 

The Pfizer-BioNTech COVID-19 Vaccine is administered as a 2-dose series, 3 weeks apart, into the muscle.

 

The Pfizer-BioNTech COVID-19 Vaccine may not protect everyone. This Fact Sheet may have been updated. For the most recent Fact Sheet, please see www.cvdvaccine.com.

 

WHAT YOU NEED TO KNOW BEFORE YOU GET THIS VACCINE?

 

WHAT IS COVID-19?

COVID-19 disease is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea.

 

WHAT IS THE PFIZER-BIONTECH COVID-19 VACCINE?

The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19.

The FDA has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine to prevent COVID-19 in individuals 16 years of age and older under an Emergency Use Authorization (EUA).

 

For more information on EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet.

 

WHAT SHOULD YOU MENTION TO YOUR VACCINATION PROVIDER BEFORE YOU GET THE PFIZER-BIONTECH COVID-19 VACCINE?

Tell the vaccination provider about all of your medical conditions, including if you:

• have any allergies

• have a fever

• have a bleeding disorder or are on a blood thinner

• are immunocompromised or are on a medicine that affects your immune system

• are pregnant or plan to become pregnant

• are breastfeeding

• have received another COVID-19 vaccine

 

WHO SHOULD GET THE PFIZER-BIONTECH COVID-19 VACCINE?

FDA has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine in individuals 16 years of age and older.

 

WHO SHOULD NOT GET THE PFIZER-BIONTECH COVID-19 VACCINE?

You should not get the Pfizer-BioNTech COVID-19 Vaccine if you:

• had a severe allergic reaction after a previous dose of this vaccine

• had a severe allergic reaction to any ingredient of this vaccine

 

WHAT ARE THE INGREDIENTS IN THE PFIZER-BIONTECH COVID-19 VACCINE?

The Pfizer BioNTech COVID-19 Vaccine includes the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3-phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose.

 

HOW IS THE PFIZER-BIONTECH COVID-19 VACCINE GIVEN?

The Pfizer-BioNTech COVID-19 Vaccine will be given to you as an injection into the muscle.

 

The Pfizer-BioNTech COVID-19 Vaccine vaccination series is 2 doses given 3 weeks apart.

 

If you receive one dose of the Pfizer-BioNTech COVID-19 Vaccine, you should receive a second dose of this same vaccine 3 weeks later to complete the vaccination series.

HAS THE PFIZER-BIONTECH COVID-19 VACCINE BEEN USED BEFORE?

The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine. In clinical trials, approximately 20,000 individuals 16 years of age and older have received at least 1 dose of the Pfizer-BioNTech COVID-19 Vaccine.

 

WHAT ARE THE BENEFITS OF THE PFIZER-BIONTECH COVID-19 VACCINE?
In an ongoing clinical trial, the Pfizer-BioNTech COVID-19 Vaccine has been shown to prevent COVID-19 following 2 doses given 3 weeks apart. The duration of protection against COVID-19 is currently unknown.

 

WHAT ARE THE RISKS OF THE PFIZER-BIONTECH COVID-19 VACCINE?

Side effects that have been reported with the Pfizer-BioNTech COVID-19 Vaccine include:

• injection site pain

• tiredness

• headache

• muscle pain

• chills

• joint pain

• fever

• injection site swelling

• injection site redness

• nausea

• feeling unwell

• swollen lymph nodes (lymphadenopathy)

 

There is a remote chance that the Pfizer-BioNTech COVID-19 Vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Pfizer-BioNTech COVID-19 Vaccine. Signs of a severe allergic reaction can include:

• Difficulty breathing

• Swelling of your face and throat

• A fast heartbeat

• A bad rash all over your body

• Dizziness and weakness

 

These may not be all the possible side effects of the Pfizer-BioNTech COVID-19 Vaccine. Serious and unexpected side effects may occur. Pfizer-BioNTech COVID-19 Vaccine is still being studied in clinical trials.

 

WHAT SHOULD I DO ABOUT SIDE EFFECTS?

If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital.

 

Call the vaccination provider or your healthcare provider if you have any side effects that bother you or do not go away.

Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to https://vaers.hhs.gov/reportevent.html. Please include “Pfizer-BioNTech COVID-19 Vaccine EUA” in the first line of box #18 of the report form.

 

In addition, you can report side effects to Pfizer Inc. at the contact information provided below.

Website  www.pfizersafetyreporting.com 
Fax number   1-866-635-8337

Telephone number  1-800-438-1985

 

WHAT IF I DECIDE NOT TO GET THE PFIZER-BIONTECH COVID-19 VACCINE?

It is your choice to receive or not receive the Pfizer-BioNTech COVID-19 Vaccine. Should you decide not to receive it, it will not change your standard medical care.

 

ARE OTHER CHOICES AVAILABLE FOR PREVENTING COVID-19 BESIDES PFIZER-BIONTECH COVID-19 VACCINE?

Currently, there is no approved alternative vaccine available for prevention of COVID-19. FDA may allow the emergency use of other vaccines to prevent COVID-19.

 

CAN I RECEIVE THE PFIZER-BIONTECH COVID-19 VACCINE WITH OTHER VACCINES?

There is no information on the use of the Pfizer-BioNTech COVID-19 Vaccine with other vaccines.

 

WHAT IF I AM PREGNANT OR BREASTFEEDING?

If you are pregnant or breastfeeding, discuss your options with your healthcare provider.

 

WILL THE PFIZER-BIONTECH COVID-19 VACCINE GIVE ME COVID-19?

No. The Pfizer-BioNTech COVID-19 Vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.

 

KEEP YOUR VACCINATION CARD

When you get your first dose, you will get a vaccination card to show you when to return for your second dose of Pfizer-BioNTech COVID-19 Vaccine. Remember to bring your card when you return.

ADDITIONAL INFORMATION

If you have questions, visit the website or call the telephone number provided below.
To access the most recent Fact Sheets, please visit the  Global website:  www.cvdvaccine.com  or Call :Telephone:  1-877-829-2619 (1-877-VAX-CO19)

 

HOW CAN I LEARN MORE?

• Ask the vaccination provider.

• Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. • Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization.

• Contact your local or state public health department.

 

WHERE WILL MY VACCINATION INFORMATION BE RECORDED?

The vaccination provider may include your vaccination information in your state/local jurisdiction’s Immunization Information System (IIS) or other designated system. This will ensure that you receive the same vaccine when you return for the second dose. For more information about IISs visit: https://www.cdc.gov/vaccines/programs/iis/about.html.

 

WHAT IS THE COUNTERMEASURES INJURY COMPENSATION PROGRAM? The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one (1) year from the date of receiving the vaccine. To learn more about this program, visit www.hrsa.gov/cicp/ or call 1-855-266-2427.

 

WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)?

The United States FDA has made the Pfizer-BioNTech COVID-19 Vaccine available under an emergency access mechanism called an EUA. The EUA is supported by a Secretary of Health and Human Services (HHS) declaration that circumstances exist to justify the emergency use of drugs and biological products during the COVID-19 pandemic.

 

The Pfizer-BioNTech COVID-19 Vaccine has not undergone the same type of review as an FDA-approved or cleared product. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, available alternatives. In addition, the FDA decision is based on the totality of scientific evidence available showing that the product may be effective to prevent COVID-19 during the COVID-19 pandemic and that the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria must be met to allow for the product to be used in the treatment of patients during the COVID-19 pandemic.

 

The EUA for the Pfizer-BioNTech COVID-19 Vaccine is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of these products, unless terminated or revoked (after which the products may no longer be used).

 

Manufactured by Pfizer Inc., New York, NY 10017

Manufactured for

BioNTech Manufacturing GmbH

An der Goldgrube 12

55131 Mainz, Germany

 

LAB-1451-0.7

Revised: December 2020

CONTACT US

140 Meisner Ave, Staten Island, NY  10306   -   Tel: 718-979-1800   -   Fax: 718-979-0089

Name *

Email *

Subject

Message

© 2019 by Eger Lutheran Homes and Services, Inc.